Founded in 1981, the Friends of St Luke’s has, thanks to the generous support of thousands of people across Ireland and abroad, continued to make a meaningful difference in the lives of adults and children undergoing cancer treatment. We are very fortunate to have this dedicated charity supporting patients and their families. The charity has its office in St Luke’s Hospital Rathgar, ensuring a close connection with patients and staff.
The Friends of St. Luke’s mission is to raise funds through its network of supporters for use in the care, cure and comfort of patients at the St Luke’s Radiation Oncology Network in Dublin, and to support clinical research at the St Luke’s Institute of Cancer Research.
The St Luke’s Cancer Research Fund works with the St. Luke’s Institute of Cancer Research as an expert partner to agree on priority areas in radiation oncology research and to organise and oversee leading research programmes.
St. Luke’s Institute of Cancer Research
St. Luke’s Institute of Cancer Research, the research arm of the St. Luke’s Radiation Oncology Network, was established in 1992 to undertake research activity in the field of cancer prevention, treatment, care and cure.
The main objectives of the Institute are:
- To fulfil the research role of The Network.
- To support research across a broad spectrum of clinical practice including therapeutic, diagnostic and laboratory work.
- To foster an environment for the training of young cancer researchers.
- To develop and encourage relationships through collaborative work with other academic and research institutes.
St. Luke’s Institute of Cancer Research
Highfield Road, Rathgar, Dublin 6.
Tel. (01) 496 0852.
Fax. (01) 497 4886.
Email. valerie.owens@slh.ie
Director of Research: Professor Sinead Brennan
The Irish Cancer Society has an office based in the St Luke’s Radiation Oncology Network at St Luke’s Hospital in Rathgar, providing on-site support and information services to patients and families.
Through its national advocacy campaigns across Ireland, the Society works to improve cancer care, expand access to treatment, and policy reform.